Tevogen Bio Holdings, Inc. (TVGN) Q1 2026 Annual Earnings
TVGN·Reported May 15, 2026·Before market open
Diluted EPS came in at $-1.61 (+49.9% YoY), beat the $-2.64 consensus by $1.03.
Diluted EPS
$-1.61beat by $1.03
Consensus: $-2.64
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Tevogen Bio Holdings, Inc.'s Q1 2026 earnings report.
Tevogen Bio Holdings, Inc. (TVGN) reported Q1 2026 earnings on May 15, 2026 before market open.
Tevogen Bio Holdings, Inc. reported diluted EPS of $-1.61 for Q1 2026.
EPS beat the consensus estimate of $-2.64 by $1.03.
Compared to the same quarter a year prior, diluted EPS grew 49.9% from $-3.21.
You can read the 10-K periodic report (0001493152-26-014326) directly on SEC EDGAR. The filing index links above go to sec.gov.